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ABSTRACT Thy-I is a membrane protein that is attached
to the plasma membrane by a glycosyl-phosphatidylinositol
anchor. Purified rat brain Thy-i could be reincorporated into
the plasma membrane of murine Thy-1l cells directly from
aqueous suspension and without the use of detergents. A
peripheral saining pattern similar to that observed for endog-
enous Thy-i was achieved. Treatment with phosphatidylinosi-
tol-specific phospholipase C removed nearly all antibody stain-
ing due to either endogenous or inserted Thy-i. Fluorescence
recovery after photobleaching (FRAP) was used to compare the
lateral mobility of endogenous and inserted Thy-i. Both forms
exhibited large lateral diffusion coefficients, but with a sub-
stantial immobile fraction (=50%) indicating that the immobile
fraction was not due either to chemical differences between
inserted and native Thy-i or to some surface Thy-i molecules
having a protein anchor. However, the inserted Thy-i failed to
activate mouse T lymphocytes upon crosslinking as assayed by
[3Hlthymidine uptake. Since Thy-i could be directly labeled
with rhodamine, the effect of the size of the labeling ligand on
the mobility obtained by the FRAP technique could be ex-
plored. Rhodamine-conjugated MRC-OX7 monoclonal anti-
body or its fragments [R-F(ab)2 or R-FabJ were compared with
rhodamine as labels for Thy-i. The measured diffusion coef-
ficients were 1.6 x 10-9, 2.0 x 10-9, and 3.2 x 10-9 cm2/sec
for Thy-i labeled with R-F(ab)2, R-Fab, and rhodamine,
respectively; mobile fractions were all in the 40-50% range.
Thus, the size of the ligand affects the lateral mobility of this
labeled membrane protein to a measurable extent.
Thy-1, a member ofthe immunoglobulin superfamily, is a cell
surface differentiation antigen present in rodent thymocytes
and brain cells (1). It has been shown recently that Thy-1
mediates adhesion of mouse thymocytes to thymic epithelial
cells through a Ca2+-independent mechanism (2), as well as
an inhibitory interaction between neurites and mature astro-
cytes (3). Mature Thy-1 is a small glycoprotein of 111 amino
acids that is attached to the plasma membrane by a glycosyl-
phosphatidylinositol (GPI) anchor covalently linked to the
carboxyl-terminal amino acid (4). Phospholipid analogues
have been inserted into plasma membranes for studies on
lateral mobility (5), and it was of interest to undertake similar
studies for a GPI-linked glycoprotein. Low levels of the
GPI-linked glycoprotein decay-accelerating factor (DAF)
have been inserted into erythrocytes by incubation of cells
with the pure molecule (6), and Thy-i has been incorporated
into mouse T lymphocytes at high levels in the presence of
polyethylene glycol (PEG) (7). In neither of these cases was
the distribution or lateral mobility of the inserted molecule
investigated. The membrane form of the variant surface
glycoprotein of Trypanosoma brucei has been reincorporated
into cultured cells from detergent solution and retains the
very low lateral mobility measured in the trypanosome coat
(8). In the present study, rat brain Thy-1 has been incorpo-
rated into murine lymphoid cells and the inserted molecule
has been compared with endogenous Thy-1 in terms of
staining patterns, lateral mobility, phosphatidylinositol-
specific phospholipase C (PIPLC) cleavability, and ability to
act as a target for mitogenesis.
MATERIALS AND METHODS
Thy-i Preparation and Labeling. Thy-1 was solubilized
from rat brain with deoxycholate and purified as described
(9). Detergent was removed by dialysis against NH4HCO3 to
yield Thy-1 in the form of an oligomer containing about 16
Thy-1 molecules (10). The isolated Thy-1 was conjugated
with Lissamine rhodamine B sulfonyl chloride (Molecular
Probes) by a procedure modified from an antibody labeling
protocol (11). Thy-1 solution (3 mg/ml) was adjusted to pH
9 with 1 M NaHCO3 (pH 9.0) before the dye was added.
Rhodamine was dissolved in acetone and added to Thy-1 in
a single addition at room temperature to give a 30:1 molar
ratio of rhodamine to protein and a final acetone concentra-
tion of about 0.4%. The reaction time was 3 min at room
temperature. The rhodamine-conjugated Thy-1 (R-Thy-1)
was then separated from free dye by passage of the reaction
mixture through a Sephadex G-50 fine column (Pharmacia),
followed by exhaustive dialysis; the final molar ratio of
fluorochrome to protein was 0.2:1.
Preparation and Labeling of Antibodies and Their Frag-
ments. MRC-OX7 mouse monoclonal antibody (IgG) against
the Thy-i.1 determinant was used for all the studies. Fab
fragments were prepared either from F(ab)2 (12) or from
intact IgG by papain digestion (11) at an enzyme/substrate
ratio of 1:100 (wt/wt) at 37°C for 17 hr. Fab fragments were
separated from the digestion mixture by chromatography on
Sephacryl S-200. After PAGE, silver staining of the Fab
preparation indicated that no intact IgG remained. Antibody
or fragments were conjugated with Lissamine rhodamine B
sulfonyl chloride as described above. The molar ratio of
fluorochrome to protein in the conjugate did not exceed 2.0.
The specificity of each antibody or fragment preparation was
demonstrated by the absence of staining of both chicken
embryo fibroblasts (Thy-i-) and AKR1/GlM1 mouse lym-
phoma (Thy-i-) cells.
Cells. AKR1/G1 (Thy-1+) and AKR1/GlM1 (Thy-i-) lym-
phoma cell lines were gifts from I. Trowbridge (Salk Institute,
La Jolla, CA). Chicken embryo fibroblasts were obtained
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from primary culture of 12-day chicken embryos. Mouse
splenocytes were obtained from spleen of BALB/c mice.
COS-1 cells were cultured as described (11). All cells were
grown in Dulbecco's modified Eagle's medium supplemented
with 10% fetal bovine serum, penicillin (100 units/ml), and
streptomycin (100 ,ug/ml) (complete medium).
Thy-i Incorporation. AKR1/GiM1 cells or mouse spleen
cells were suspended at 1061i07 cells per ml in complete
medium. A small drop of suspended cells was placed on a
coverslip (12 mm x 12 mm) and incubated for 20 min at 370C,
enabling 60-70% of the cells to attach to the glass substrate.
Attached cells were placed upside down on a 20-blI droplet of
Thy-1 (350 gg/ml) in phosphate-buffered saline with Ca2+
and Mg2+ [PBS(+)]. The cells were incubated in the Thy-1
solution for 20 min at 370C and carefully washed twice in
PBS(+). Cells were then incubated with antibody or its
fragments for 10 min at room temperature. Coverslips were
mounted onto a metal chamber slide in PBS(+) for micro-
scopic examination and measurements of fluorescence re-
covery after photobleaching (FRAP). Thy-1 was inserted into
COS cell cultures by a protocol identical to that used for
attached AKR1/GiM1 cells.
Thy-1 was also incorporated into suspension cells. AKR1/
GiM1 or mouse splenocytes in suspension (2-5 x 106 cells
per ml) were pelleted and resuspended to 3 x 107 cells per ml
in complete medium. Thy-1 (40 ILI at 2.5 mg/ml) was added
to 20 ul of cell suspension. This mixture was incubated at
370C in CO2 incubator for 20 min and washed three times with
PBS(+).
Mitogenesis Assay. The assay was based on previous work
(7) and modified slightly. Approximately 2 x 106 splenocytes
from BALB/c mice into which rat brain Thy-1 had been
inserted were incubated with appropriate anti-Thy-1 antibod-
ies at 4°C for 30 min and then washed prior to incubation with
secondary antibodies and addition of phorbol 12-myristate
13-acetate (25 ng/ml). Cells (-2 x 105 per well) were plated
in 96-well microtiter plates in complete medium (0.1 ml per
well) and placed in a humidified CO2 incubator at 37°C. Each
well received 0.4 ,Ci (14.8 kBq) of [3H]thymidine 4 hr before
the end of incubation period, and the uptake of radioactivity
was determined after harvesting onto glass-fiber filters.
PIPLC Assay. A coverslip with attached AKR1/GlM1
cells into which Thy-1 had been inserted was placed upside
down on a 12-,u droplet of 0.01 unit of PIPLC (ICN) in
Dulbecco's modified Eagle's medium with 1% fetal bovine
serum. The cells were incubated for 30 min at 37°C, carefully
washed twice in PBS(+), and then incubated with antibody
FIG. 1. Fluorescence staining of native and inserted Thy-1. (a and b) Native Thy-i in AKR1/G1 (Thy-1+) cells (a) and inserted Thy-1 in
AKR1/G1Ml (Thy-l-) cells (b) have similar staining patterns. Both cell samples were fixed before staining with R-F(ab)2 fragment (60 ,g/ml)
of MRC-OX7. (c) AKR1/GlM1 cells were fixed after incubation with R-Thy-1 (360 ,ug/ml) for 20 min at 37°C; note that some internalization
occurred (see text). (d) Patching (small arrow) and capping (large arrow) of inserted Thy-1 in AKR1/GlM1 cells. After Thy-1 insertion, the cells
were incubated with MRC-OX7 F(ab)2 (60 ttg/ml) followed by fluorescein-labeled second antibody. The cells were photographed after 30 min
to demonstrate patching and capping over time. (e andf) Confocal images of inserted R-Thy-1 near midsection (e) and near dorsal surface (f)
of AKRi/GlMi cells with the microscope set at full confocality (smallest emission pinhole setting). (Bars = 10 Am.)
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or its fragments for 10 min at room temperature. Coverslips
were mounted onto a metal chamber slide in PBS(+) for
microscopic examination.
Fluorescence Microscopy. Fluorescence images were taken
either with a Zeiss IM35 or a Nikon Optiphot-2 microscope
using phase contrast and rhodamine optics. Identical expo-
sures and development times were employed for the micro-
graphs in each figure. For fixation, cells were incubated with
3.6% formaldehyde in PBS(+) for 15 min at room tempera-
ture. Cells were then washed extensively with PBS(+) before
antibody labeling.
Confocal Microscopy. Confocal images were acquired on
the Bio-Rad MRC-600 microscope using rhodamine optics
and at nearly full confocality.
FRAP. Measurements were made at room temperature
employing a x40 oil objective (n.a., 1.3), and recovery was
recorded as described (13).
RESULTS AND DISCUSSION
Insertion of Thy-i. Thy-i incorporation into lymphocytes
was initially attempted by incubation in the presence of
10-20o polyethylene glycol (PEG), since this had yielded
stable incorporation of 100,000-500,000 Thy-i molecules per
cell (7). However, in the present study, Thy-i incorporated
in this way yielded a punctate staining pattern and no
fluorescence recovery was seen after photobleaching.
Insertion of Thy-i by incubation in buffered salt solution
yielded about 40,000 molecules per cell on lymphocytes (7),
and when this procedure was tried with AKR1/GlMl (Thy-
1-) cells, a peripheral staining pattern (Fig. lb) was seen
similar to that observed for native Thy-i on AKR1/G1
(Thy-l+) cells (Fig. la). Addition of secondary antibody
caused prominent patching and capping of the inserted Thy-i
(Fig. id), similar to that observed with native Thy-1 in
AKRl/Gl cells (data not shown). Thus, with respect to the
initial distribution and antibody-induced aggregation, native
and inserted Thy-1 behaved similarly.
When Thy-1 directly labeled with rhodamine (R-Thy-1)
was incorporated into AKR1/GlM1 cells, the distribution
pattern (Fig. ic) was similar to that seen with the Thy-1
labeled with antibody, although the staining pattern was
consistently fainter with some aggregation and internaliza-
tion visible in some ofthe cells. This view was extended using
confocal microscopy of R-Thy-l inserted into AKR1/GlMl
cells. Aggregates and/or internalized materials appeared
near the poles of the cells-either the substrate attached end
or the free hanging "pole" (Fig. l). Near the midsection of
the cell "ring," staining was observed with no internalized
material visible (Fig. le). It is curious that Thy-i seems
aggregated at cell-cell or cell-substrate contacts. The nature
and functionality of these aggregates are not clear. Several
experiments indicated that AKRl/GlM1 cells were capable
of internalization under the conditions employed for Thy-1
insertion. First, without any Thy-i insertion, R-Fab frag-
ments ofMRC-OX7 antibodies incubated with AKR1/GlM1
cells were internalized to a limited extent after 10 min at room
temperature without any staining of the plasma membrane.
Second, when antibody staining of Thy-1 inserted into
AKR1/GlM1 cells was done on ice, internalized staining was
much less apparent (data not shown).
PIPLC digestion of the inserted material was employed as
a further check of correct insertion. The reasoning was that
release of the Thy-1 ectodomain would probably result only
if the GPI anchor ofThy-1 were correctly intercalated into the
bilayer. Indeed, PIPLC treatment resulted in nearly complete
loss of fluorescence (Fig. 2), indicating that the inserted
Thy-i could be cleaved by PIPLC. Cleavage of endogenous
Thy-i in AKRl/Gl cells by PIPLC was also almost complete
(data not shown).
In addition to using PEG as an agent to facilitate insertion
of Thy-1 into cells, we also tested Pluronic detergent (BASF
b
FIG. 2. PIPLC treatment ofthe inserted Thy-i. (a) Fluorescence image ofinserted Thy-1 in AKRi/GlMi cells that were stained with R-F(ab)
fragment (60 Ag/ml) ofMRC-OX7 at 40C to minimize internalization. (b) Phase-contrast image ofsame cells as in a. (c) PIPLC treatment removed
most offluorescence staining of inserted Thy-i in AKR1/GlMi cells; arrows show positions of cells as obtained from companion phase-contrast
image (d) of cells in c. (Bar = 10 Am.)
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Table 1. Mobility of endogenous and inserted Thy-1
Mode of
expression D, Mobile Number of
Cells of Thy-1 (cm2/sec) x 109 fraction, % measurements
AKR1/G1 Endogenous 2.0 ± 0.6 45 ± 10 22
AKR1/GlMl Inserted 2.1 ± 0.5 46 ± 10 32
CEF* Inserted 1.6 ± 0.5 49 ± 8 20
COS-1 Transfected (17) 2.7 ± 1.0 55 ± 10 32
COS-1 Inserted 1.9 ± 0.6 45 ± 12 16
Cells were labeled with MRC-OX7 Fab fragments (100 ,g/ml). D, mobile fraction (mean ± SD).
*CEF, chicken embryo fibroblasts.
Wyandotte, Wyandotte, MI). Cells were incubated with
Thy-1 plus the detergent at low levels (5-100 ,ug/ml); a
diffuse, peripheral staining pattern was obtained after label-
ing the cells with antibody. However, most cells "blebbed"
within 15 min of treatment with the Pluronic detergent, and
it was concluded that incorporation of Thy-1 in the presence
of agents that give membrane destabilization was not satis-
factory for studies on lateral mobility.
Lateral Mobility of Inserted Thy-i. The inserted Thy-1 was
laterally mobile, and the diffusion coefficients and mobile
fractions were similar for inserted and native Thy-1 in lym-
phoma cells (Table 1). In addition, the mobility of Thy-1
inserted into COS-1 cells was similar to the mobility ofThy-1
transiently expressed in transfected COS-1 cells (Table 1).
Thus, native and inserted Thy-1 exhibited similar lateral
mobility. It is especially curious that the mobile fraction of
inserted Thy-1 was approximately that of native Thy-1. The
substantial immobile fraction of Thy-1 and other GPI-linked
proteins is an unexpected and unexplained characteristic of
these proteins. Although it could be argued that the immobile
fractions are photochemical artifacts induced by photob-
leaching, it is also significant that similar immobile fractions
were obtained whether directly labeled Thy-1 or antibody-
labeled Thy-1 was measured (Fig. 3). One might expect that
if photobleaching were producing the immobile fraction the
photochemical environments of the two probes would differ
enough that different immobile fractions would be measured.
Furthermore, other work suggests that different populations
of endogenous Thy-1 exist. The fact that 10-20% of Thy-1 in
T-lymphoma cells could not be solubilized by nonionic
detergent was taken to indicate that this fraction of the
antigen is a constituent of a heteropolymeric complex of
detergent-resistant membrane proteins (14). In addition, it
was recently shown that GPI-linked surface molecules, in-
cluding Thy-1, were associated with the cytoplasmic protein
tyrosine kinase p56lck (15), indicating that such GPI-linked
proteins indirectly interact with proteins on the inner face of
the plasma membrane, which perhaps leads to immobiliza-
tion of the lipid-linked protein.
This work also shows that the immobile fraction is not due
to chemical differences between the reinserted rat brain
Thy-1 and the endogenous murine Thy-1. Further, our work
demonstrates that the immobile fraction of native Thy-1
could not be due to Thy-1 with a protein anchor, since all of
the reinserted antigen, which has a similar immobile fraction
as native Thy-1, is GPI-linked. These results support other
data showing that the mature glycoprotein is exclusively
GPI-linked (16).
Effect of Size of the Labeling Ligand on the Measured
Lateral Mobility. Photobleaching measurements of the mo-
bility of membrane proteins usually require a fluorescent
antibody to label the relevant antigen. The effect of the
antibody label has been a long-standing concern in measure-
ments of membrane protein lateral mobility by the FRAP
technique. The ability to insert a directly conjugated Thy-1
into the membrane allowed a comparison of the lateral
mobility ofR-Thy-1 with that of antibody-labeled Thy-1 to be
made. Fig. 3 shows the mobility of inserted Thy-1 as a
function of labeling ligand size employing R-IgG, R-F(ab)2,
R-Fab, and rhodamine as probes. Particularly in the case of
R-Thy-i, the laser beam was positioned to avoid aggregated
and/or internalized material. A gradual, monotonic increase
in the lateral diffusion coefficients was observed as the size











FIG. 3. Effect of labeling ligand size on lateral mobility of Thy-1
in AKR1/G1 and AKR1/GlM1. (Top) Schematic of various ligands
(hatched ovals) bound to Thy-1 (stippled oval); *, R, rhodamine.
(Middle) Diffusion coefficient for the various ligand/Thy-1 combi-
nations. (Bottom) Mobile fraction for the various ligand/Thy-1
combinations (hatched bars, inserted Thy-1; stippled bars, endoge-
nous Thy-1). Antibodies or their fragments were used at the following
nominal concentrations: 60 jig/ml (IgG), 80 Ag/ml [F(ab)2], and 100
,ug/ml (Fab). Inserted Thy-1 labeled with IgG yielded no mobile
Thy-1 in repeated attempts. The reasons for this are unknown.
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mine. Mobile fractions remained in the range of 40-60%o for
all ligands measured. In the case of Thy-1, at least, the Fab
fragment used for FRAP reduced the measured diffusion
coefficient to about two-thirds of the unliganded value. This
effect of ligand size can be contrasted to a recent study (17)
showing no correlation between ectodomain size and lateral
mobility for a series of unrelated proteins.
Inserted Thy-i as a Target for Mitogenesis. Although the
results above suggested that inserted Thy-1 was intercalated
into the lipid bilayer via its GPI anchor, the functionality of
this insertion remained in question. It was therefore of
interest to determine whether this Thy-1 could function as a
target for mitogenesis, as is the case for endogenous Thy-1.
Anti-Thy-1 antibodies are generally mitogenic for mouse T
cells if the antibody is crosslinked with an anti-immunoglo-
bulin second antibody and the cells are cultured in the
presence of phorbol myristate acetate (18). Rat brain Thy-i
(Thy-1.1 determinant) was inserted into mouse lymphocytes
carrying the Thy-1.2 allotype and mitogenesis was tested with
the MRC-OX7 (anti-Thy-i.1) antibody as well as an antibody
against Thy-1.2. The mitogenic effect was seen with the
endogenous Thy-1 but not with the inserted molecule (data
not shown). This negative result had also been observed in
the experiments where Thy-1 was inserted in the presence of
PEG (7).
The reasons for the failure of inserted Thy-1 to act as a
target for mitogenesis are unclear and are in contrast to
studies where Thy-1 was introduced by transfection into
human Jurkat cells and functioned as a target for signal
transduction (19). It is possible that some structural differ-
ence between inserted and endogenous Thy-1 may account
for the functional activity. For example, it could be that some
oxidation of the lipid anchor has occurred in the purification
of Thy-1. Alternatively, tissue-specific posttranslational
modifications of the molecule may be important. The carbo-
hydrate structures of brain Thy-1 are different from those of
the lymphoid forms of the molecule (20), and there are
differences in some carbohydrates attached to the backbone
of the GPI anchor (4). These structural differences may lead
to a failure of inserted Thy-1 to appropriately enter a signal-
transduction pathway, such as those mediated by protein
kinases (15).
The current data show that Thy-1 can be inserted into cells
in a manner that mimics the biophysical properties of endog-
enous Thy-1, and this system should be of further interest in
studies on membrane dynamics and domain structure (21).
However, the requirements for functional insertion remain to
be established.
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